Methenamine Mandelate Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Methenamine Mandelate Tablets contain NLT 95.0% and NMT 105.0% of the labeled amount of methenamine mandelate (C6H12N4 · C8H8O3).
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
Sample: Triturate a portion of finely powdered Tablets, equivalent to 5.0 mg of methenamine mandelate, with 5 mL of chloroform, and pass through a 0.45-μm membrane filter. Evaporate the solvent, and allow the residue to air-dry.
Acceptance criteria: Meet the requirements
3 ASSAY
Procedure
Sample solution: Transfer an equivalent to 60 mg of methenamine mandelate, from NLT 20 finely powdered Tablets, to a 250-mL conical flask. Add 15 mL of dehydrated alcohol, stir to dissolve, and add 40 mL of chloroform.
Titrimetric system
Mode: Direct titration
Titrant: 0.05 N silver nitrate in dehydrated alcohol prepared as follows. Dissolve by stirring 8.5 g of silver nitrate in 1000 mL of dehydrated alcohol. Transfer 100 mg of sodium chloride, previously dried at 110° for 2 h, to a 100-mL beaker, and dissolve in 50 mL of water. Titrate with the silver nitrate solution to the potentiometric endpoint, using a silver billet indicator electrode and a silver–silver chloride double-junction reference electrode containing a potassium nitrate salt bridge. Calculate the normality of the titrant.
Endpoint detection: Potentiometric
Analysis: Titrate the Sample solution with Titrant, determining the endpoint potentiometrically, using a silver billet indicator electrode and a silver–silver chloride double-junction reference electrode containing a potassium nitrate salt bridge. Each mL of 0.05 N silver nitrate is equivalent to 7.308 mg of methenamine mandelate (C6H12N4 · C8H8O3).
Acceptance criteria: 95.0%–105.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
For uncoated or plain coated Tablets
Medium: Water; 900 mL
Apparatus 1: 100 rpm
Time: 45 min
Standard solution: USP Methenamine Mandelate RS in Medium
Instrumental conditions
Mode: UV
Analytical wavelength: UV maximum at about 257 nm
Analysis: Determine the amount of methenamine mandelate (C6H12N4 · C8H8O3) dissolved in the portion of the solution under test, passed through a filter of 0.45-μm pore size and suitably diluted with Medium, if necessary, in comparison with a Standard solution having a known concentration of USP Methenamine Mandelate RS in the same Medium.
Tolerances: NLT 75% (Q) of the labeled amount of methenamine mandelate (C6H12N4 · C8H8O3) is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers.
USP Reference Standards 〈11〉
USP Methenamine Mandelate RS

